Mirati Therapeutics, Inc.

FEDERATED HERMES, INC.

Report date

12/31/2023

Quarter

2023 Q4

Filed

1/31/2024

Shares

1,440

Value ($000)

85

Weight

0.0%

2019 Q4 - 2023 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	1/31/2024	85	0.0%	1,440	12/31/2023
2022 Q4	2/13/2023	1	0.0%	25	12/31/2022
2022 Q3	11/14/2022	18,177	0.1%	260,270	9/30/2022
2022 Q2	9/16/2022	17,800	0.0%	265,156	6/30/2022
2022 Q1	5/13/2022	21,312	0.0%	259,207	3/31/2022
2021 Q4	2/14/2022	37,971	0.1%	258,848	12/31/2021
2021 Q3	11/15/2021	27,492	0.1%	155,400	9/30/2021
2021 Q2	8/16/2021	24,989	0.0%	154,700	6/30/2021
2021 Q1	5/13/2021	26,866	0.1%	156,839	3/31/2021
2020 Q4	2/12/2021	53,142	0.1%	241,952	12/31/2020
2020 Q3	11/12/2020	35,150	0.1%	211,685	9/30/2020
2020 Q2	8/13/2020	20,317	0.1%	177,950	6/30/2020
2020 Q1	5/13/2020	1,161	0.0%	15,101	3/31/2020
2019 Q4	2/14/2020	428	0.0%	3,319	12/31/2019